Guangzhou courts made a landmark ruling on a Class Action Lawsuit against Kangmei Pharmaceutical This increases the costs of fraud and would boost investor's confidence in China's capital markets
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.